StockrabitBrowse analysts
Analyst questions

Tarang Agrawal

Old Bridge PMS
NATCOPHARM

Natco Pharma Limited

All company calls
Natco Pharma Limited CC-Mar24.pdf
28 May 2024
Open call
  1. Just 1 question. The 2 years that Revlimid has come through, how is the pricing traversed say from the first time that you launched till say Q4 of FY '24? And in the short term, in the next 20, 21 months, do you have a view on the stability of pricing?

    Read in transcript